Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. (Q51373546)

4 April 2018

title

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. (English)

1 reference

4 April 2018

1 reference

Luke Norton

2

0 references

Ralph A. DeFronzo

5

object named as

Ralph A DeFronzo

1 reference

4 April 2018

Mustafa Kanat

1

1 reference

4 April 2018

Diedre Winnier

3

1 reference

4 April 2018

Chris Jenkinson

4

1 reference

4 April 2018

Muhammad A Abdul-Ghani

6

1 reference

4 April 2018

publication date

8 May 2011

1 reference

4 April 2018

published in

Acta Diabetologica

1 reference

4 April 2018

volume

48

1 reference

4 April 2018

issue

3

1 reference

4 April 2018

page(s)

209-217

1 reference

4 April 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Splanchnic insulin metabolism in obesity. Influence of body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Accurate assessment of beta-cell function: the hyperbolic correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Loss of beta cell function as fasting glucose increases in the non-diabetic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

Excessive maternal transmission of diabetes in Japanese families with young-onset type 2 diabetes and insulin secretion defect according to clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0285-X

10.1007/S00592-011-0285-X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018